The Afterlife of the California Stem Cell Agency: Venture Philanthropy and Big Pharma
The $3 billion California stem cell agency, which is facing its possible demise in five years, is exploring an afterlife that dips into "venture philanthropy" on a national level as well as investment ties with Big Pharma.
The Golden State's unprecedented research program laid out those possibilities in a "transition plan" sent this week to Gov. Jerry B…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.